Pliant Therapeutics
Candace Mae Laxamana, PMP, serves as Associate Director at Pliant Therapeutics since April 2023, following a role as Senior Manager of Portfolio and Project Management at Alkahest, Inc. from April 2021 to April 2023, where support was provided for various projects including research and regulatory phases. Prior experience includes serving as Project Manager for Regulatory Chemistry and Nonclinical Toxicology at JUUL Labs and earlier roles at UNITY Biotechnology and BlackThorn Therapeutics as a Research Associate and Research Assistant, respectively. Educational qualifications include two Bachelor of Science degrees in Molecular Biology and Biochemistry from the University of San Francisco.
Pliant Therapeutics
Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.